Works by Clark, Jeffrey W.

Results: 93
    1

    Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation therapy.

    Published in:
    European Radiology, 2022, v. 32, n. 4, p. 2470, doi. 10.1007/s00330-021-08304-y
    By:
    • Noda, Yoshifumi;
    • Pisuchpen, Nisanard;
    • Mercaldo, Nathaniel D.;
    • Sekigami, Yurie;
    • Michelakos, Theodoros;
    • Parakh, Anushri;
    • Wo, Jennifer Y.;
    • Qadan, Motaz;
    • Ferrone, Cristina;
    • Lillemoe, Keith D.;
    • Ryan, David P.;
    • Clark, Jeffrey W.;
    • Fernandez-Del Castillo, Carlos;
    • Hong, Theodore S.;
    • Kambadakone, Avinash R.
    Publication type:
    Article
    2

    Chemoradiation‐Related Lymphopenia and Its Association with Survival in Patients with Squamous Cell Carcinoma of the Anal Canal.

    Published in:
    Oncologist, 2020, v. 25, n. 12, p. 1015, doi. 10.1634/theoncologist.2019-0759
    By:
    • Lee, Grace;
    • Kim, Daniel W.;
    • Muralidhar, Vinayak;
    • Mitra, Devarati;
    • Horick, Nora K.;
    • Eyler, Christine E.;
    • Hong, Theodore S.;
    • Drapek, Lorraine C.;
    • Allen, Jill N.;
    • Blaszkowsky, Lawrence S.;
    • Giantonio, Bruce;
    • Parikh, Aparna R.;
    • Ryan, David P.;
    • Clark, Jeffrey W.;
    • Wo, Jennifer Y.
    Publication type:
    Article
    3
    4
    5

    Familial Gastric Cancers.

    Published in:
    Oncologist, 2015, v. 20, n. 12, p. 1365, doi. 10.1634/theoncologist.2015-0205
    By:
    • Setia, Namrata;
    • Clark, Jeffrey W.;
    • Duda, Dan G.;
    • Hong, Theodore S.;
    • Kwak, Eunice L.;
    • Mullen, John T.;
    • Lauwers, Gregory Y.
    Publication type:
    Article
    6
    7

    The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.

    Published in:
    PLoS ONE, 2022, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0265767
    By:
    • Zafar, Amna;
    • Drobni, Zsofia D.;
    • Lei, Matthew;
    • Gongora, Carlos A.;
    • Quinaglia, Thiago;
    • Lou, Uvette Y.;
    • Mosarla, Ramya;
    • Murphy, Sean P.;
    • Jones-O'Connor, Maeve;
    • Mahmood, Ali;
    • Hartmann, Sarah;
    • Gilman, Hannah K.;
    • Weekes, Colin D.;
    • Nipp, Ryan;
    • Clark, John R.;
    • Clark, Jeffrey W.;
    • Blaszkowsky, Lawrence S.;
    • Tavares, Erica;
    • Neilan, Tomas G.
    Publication type:
    Article
    8

    Clinical impact of PET/MRI in oligometastatic colorectal cancer.

    Published in:
    British Journal of Cancer, 2021, v. 125, n. 7, p. 975, doi. 10.1038/s41416-021-01494-8
    By:
    • Furtado, Felipe S.;
    • Suarez-Weiss, Krista E.;
    • Vangel, Mark;
    • Clark, Jeffrey W.;
    • Cusack, James C.;
    • Hong, Theodore;
    • Blaszkowsky, Lawrence;
    • Wo, Jennifer;
    • Striar, Robin;
    • Umutlu, Lale;
    • Daldrup-Link, Heike E.;
    • Groshar, David;
    • Rocco, Ricciardi;
    • Bordeianou, Liliana;
    • Anderson, Mark A.;
    • Mojtahed, Amirkasra;
    • Qadan, Motaz;
    • Ferrone, Cristina;
    • Catalano, Onofrio A.
    Publication type:
    Article
    9

    Clinical impact of PET/MRI in oligometastatic colorectal cancer.

    Published in:
    2021
    By:
    • Furtado, Felipe S;
    • Suarez-Weiss, Krista E;
    • Vangel, Mark;
    • Clark, Jeffrey W;
    • Cusack, James C;
    • Hong, Theodore;
    • Blaszkowsky, Lawrence;
    • Wo, Jennifer;
    • Striar, Robin;
    • Umutlu, Lale;
    • Daldrup-Link, Heike E;
    • Groshar, David;
    • Rocco, Ricciardi;
    • Bordeianou, Liliana;
    • Anderson, Mark A;
    • Mojtahed, Amirkasra;
    • Qadan, Motaz;
    • Ferrone, Cristina;
    • Catalano, Onofrio A
    Publication type:
    journal article
    10

    Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.

    Published in:
    Oncologist, 2015, v. 20, n. 9, p. 1019, doi. 10.1634/theoncologist.2015-0210
    By:
    • Goyal, Lipika;
    • Govindan, Aparna;
    • Sheth, Rahul A.;
    • Nardi, Valentina;
    • Blaszkowsky, Lawrence S.;
    • Faris, Jason E.;
    • Clark, Jeffrey W.;
    • Ryan, David P.;
    • Kwak, Eunice L.;
    • Allen, Jill N.;
    • Murphy, Janet E.;
    • Saha, Supriya K.;
    • Hong, Theodore S.;
    • Wo, Jennifer Y.;
    • Ferrone, Cristina R.;
    • Tanabe, Kenneth K.;
    • Chong, Dawn Q.;
    • Deshpande, Vikram;
    • Borger, Darrell R.;
    • Iafrate, A. John
    Publication type:
    Article
    11

    FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience.

    Published in:
    Oncologist, 2013, v. 18, n. 5, p. 542, doi. 10.1634/theoncologist.2012-0435
    By:
    • Faris, Jason E.;
    • Blaszkowsky, Lawrence S.;
    • McDermott, Shaunagh;
    • Guimaraes, Alexander R.;
    • Szymonifka, Jackie;
    • Huynh, Mai Anh;
    • Ferrone, Cristina R.;
    • Wargo, Jennifer A.;
    • Allen, Jill N.;
    • Dias, Lauren E.;
    • Kwak, Eunice L.;
    • Lillemoe, Keith D.;
    • Thayer, Sarah P.;
    • Murphy, Janet E.;
    • Zhu, Andrew X.;
    • Sahani, Dushyant V.;
    • Wo, Jennifer Y.;
    • Clark, Jeffrey W.;
    • Fernandez‐del Castillo, Carlos;
    • Ryan, David P.
    Publication type:
    Article
    12

    Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping.

    Published in:
    Oncologist, 2012, v. 17, n. 1, p. 72, doi. 10.1634/theoncologist.2011-0386
    By:
    • BORGER, DARRELL R.;
    • TANABE, KENNETH K.;
    • FAN, KENNETH C.;
    • LOPEZ, HECTOR U.;
    • FANTIN, VALERIA R.;
    • STRALEY, KIMBERLY S.;
    • SCHENKEIN, DAVID P.;
    • HEZEL, ARAM F.;
    • ANCUKIEWICZ, MAREK;
    • LIEBMAN, HANNAH M.;
    • KWAK, EUNICE L.;
    • CLARK, JEFFREY W.;
    • RYAN, DAVID P.;
    • DESHPANDE, VIKRAM;
    • DIAS-SANTAGATA, DORA;
    • ELLISEN, LEIF W.;
    • ZHU, ANDREW X.;
    • IAFRATE, A. JOHN
    Publication type:
    Article
    13
    14
    15

    A Safety and Survival Analysis of Neoadjuvant Bevacizumab with Standard Chemoradiation in a Phase I/II Study Compared with Standard Chemoradiation in Locally Advanced Rectal Cancer.

    Published in:
    Oncologist, 2010, v. 15, n. 8, p. 845, doi. 10.1634/theoncologist.2010-0030
    By:
    • WILLETT, CHRISTOPHER G.;
    • DUDA, DAN G.;
    • ANCUKIEWICZ, MAREK;
    • SHAH, MIRA;
    • CZITO, BRIAN G.;
    • BENTLEY, REX;
    • HIROSHI FUJITA;
    • LAUWERS, GREGORY Y.;
    • CARROLL, MADELINE;
    • TYLER, DOUGLAS;
    • MANTYH, CHRISTOPHER;
    • SHELLITO, PAUL;
    • CHUNG, DANIEL C.;
    • CLARK, JEFFREY W.;
    • JAIN, RAKESH K.
    Publication type:
    Article
    16

    Plasma Soluble VEGFR-1 Is a Potential Dual Biomarker of Response and Toxicity for Bevacizumab with Chemoradiation in Locally Advanced Rectal Cancer.

    Published in:
    Oncologist, 2010, v. 15, n. 6, p. 577, doi. 10.1634/theoncologist.2010-0029
    By:
    • Duda, Dan G.;
    • Willett, Christopher G.;
    • Ancukiewicz, Marek;
    • Di Tomaso, Emmanuelle;
    • Shah, Mira;
    • Czito, Brian G.;
    • Bentley, Rex;
    • Poleski, Martin;
    • Lauwers, Gregory Y.;
    • Carroll, Madeline;
    • Tyler, Douglas;
    • Mantyh, Christopher;
    • Shellito, Paul;
    • Clark, Jeffrey W.;
    • Jain, Rakesh K.
    Publication type:
    Article
    17
    18
    19

    Primary tumor sidedness is an independent prognostic marker for survival in metastatic colorectal cancer: Results from a large retrospective cohort with mutational analysis.

    Published in:
    Cancer Medicine, 2018, v. 7, n. 7, p. 2934, doi. 10.1002/cam4.1558
    By:
    • Kamran, Sophia C.;
    • Clark, Jeffrey W.;
    • Zheng, Hui;
    • Borger, Darrell R.;
    • Blaszkowsky, Lawrence S.;
    • Allen, Jill N.;
    • Kwak, Eunice L.;
    • Wo, Jennifer Y.;
    • Parikh, Aparna R.;
    • Nipp, Ryan D.;
    • Murphy, Janet E.;
    • Goyal, Lipika;
    • Zhu, Andrew X.;
    • Iafrate, A. John;
    • Corcoran, Ryan B.;
    • Ryan, David P.;
    • Hong, Theodore S.
    Publication type:
    Article
    20
    21

    Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy.

    Published in:
    2017
    By:
    • Keehoon Jung;
    • Takahiro Heishi;
    • Khan, Omar F.;
    • Kowalski, Piotr S.;
    • Incio, Joao;
    • Rahbari, Nuh N.;
    • Euiheon Chung;
    • Clark, Jeffrey W.;
    • Willett, Christopher G.;
    • Luster, Andrew D.;
    • Seok Hyun Yun;
    • Langer, Robert;
    • Anderson, Daniel G.;
    • Padera, Timothy P.;
    • Jain, Rakesh K.;
    • Dai Fukumura;
    • Jung, Keehoon;
    • Heishi, Takahiro;
    • Chung, Euiheon;
    • Yun, Seok Hyun
    Publication type:
    journal article
    22
    23

    Phase 1 study of <i>N</i><sup>1</sup>,<i>N</i><sup>11</sup>-diethylnorspermine (DENSPM) in patients with advanced hepatocellular carcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 6, p. 1305, doi. 10.1007/s00280-013-2293-8
    By:
    • Goyal, Lipika;
    • Supko, Jeffrey G.;
    • Berlin, Jordan;
    • Blaszkowsky, Lawrence S.;
    • Carpenter, Amanda;
    • Heuman, Douglas M.;
    • Hilderbrand, Sarah L.;
    • Stuart, Keith E.;
    • Cotler, Scott;
    • Senzer, Neil N.;
    • Chan, Emily;
    • Berg, Carl L.;
    • Clark, Jeffrey W.;
    • Hezel, Aram F.;
    • Ryan, David P.;
    • Zhu, Andrew X.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Improving staging of rectal cancer in the pelvis: the role of PET/MRI.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 4, p. 1235, doi. 10.1007/s00259-020-05036-x
    By:
    • Catalano, Onofrio A.;
    • Lee, Susanna I.;
    • Parente, Chiara;
    • Cauley, Christy;
    • Furtado, Felipe S.;
    • Striar, Robin;
    • Soricelli, Andrea;
    • Salvatore, Marco;
    • Li, Yan;
    • Umutlu, Lale;
    • Cañamaque, Lina Garcia;
    • Groshar, David;
    • Mahmood, Umar;
    • Blaszkowsky, Lawrence S.;
    • Ryan, David P.;
    • Clark, Jeffrey W.;
    • Wo, Jennifer;
    • Hong, Theodore S.;
    • Kunitake, Hiroko;
    • Bordeianou, Liliana
    Publication type:
    Article
    33

    Clinical impact of PET/MR in treated colorectal cancer patients.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 11, p. 2260, doi. 10.1007/s00259-019-04449-7
    By:
    • Amorim, Barbara J.;
    • Hong, Theodore S.;
    • Blaszkowsky, Lawrence S.;
    • Ferrone, Cristina R.;
    • Berger, David L.;
    • Bordeianou, Liliana G.;
    • Ricciardi, Rocco;
    • Clark, Jeffrey W.;
    • Ryan, David P.;
    • Wo, Jennifer Y.;
    • Qadan, Motaz;
    • Vangel, Mark;
    • Umutlu, Lale;
    • Groshar, David;
    • Cañamaques, Lina G.;
    • Gervais, Debra A.;
    • Mahmood, Umar;
    • Rosen, Bruce R.;
    • Catalano, Onofrio A.
    Publication type:
    Article
    34
    35

    Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study.

    Published in:
    Molecular Imaging & Biology, 2021, v. 23, n. 3, p. 456, doi. 10.1007/s11307-020-01569-7
    By:
    • Furtado, Felipe S.;
    • Ferrone, Cristina R.;
    • Lee, Susanna I.;
    • Vangel, Mark;
    • Rosman, David A.;
    • Weekes, Colin;
    • Qadan, Motaz;
    • Fernandez-Del Castillo, Carlos;
    • Ryan, David P.;
    • Blaszkowsky, Lawrence S.;
    • Hong, Theodore S.;
    • Clark, Jeffrey W.;
    • Striar, Robin;
    • Groshar, David;
    • Cañamaque, Lina G.;
    • Umutlu, Lale;
    • Catalano, Onofrio A.
    Publication type:
    Article
    36
    37

    Type-I HTLV antibody in urban and rural Ghana, West Africa.

    Published in:
    International Journal of Cancer, 1984, v. 34, n. 2, p. 215, doi. 10.1002/ijc.2910340212
    By:
    • Biggar, Robert J.;
    • Saxinger, Carl;
    • Gardiner, Charlotte;
    • Collins, William E.;
    • Levine, Paul H.;
    • Clark, Jeffrey W.;
    • Nkrumah, Francis K.;
    • Blattner, William A.
    Publication type:
    Article
    38

    Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases.

    Published in:
    Science Translational Medicine, 2016, v. 8, n. 360, p. 1, doi. 10.1126/scitranslmed.aaf5219
    By:
    • Rahbari, Nuh N.;
    • Kedrin, Dmitriy;
    • Incio, Joao;
    • Hao Liu;
    • Ho, William W.;
    • Nia, Hadi T.;
    • Edrich, Christina M.;
    • Keehoon Jung;
    • Daubriac, Julien;
    • Ivy Chen;
    • Takahiro Heishi;
    • Martin, John D.;
    • Yuhui Huang;
    • Maimon, Nir;
    • Reissfelder, Christoph;
    • Weitz, Jurgen;
    • Boucher, Yves;
    • Clark, Jeffrey W.;
    • Grodzinsky, Alan J.;
    • Duda, Dan G.
    Publication type:
    Article
    39
    40
    41
    42
    43

    Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.

    Published in:
    EMBO Molecular Medicine, 2010, v. 2, n. 5, p. 146, doi. 10.1002/emmm.201000070
    By:
    • Dias-Santagata, Dora;
    • Akhavanfard, Sara;
    • David, Serena S.;
    • Vernovsky, Kathy;
    • Kuhlmann, Georgiana;
    • Boisvert, Susan L.;
    • Stubbs, Hannah;
    • McDermott, Ultan;
    • Settleman, Jeffrey;
    • Kwak, Eunice L.;
    • Clark, Jeffrey W.;
    • Isakoff, Steven J.;
    • Sequist, Lecia V.;
    • Engelman, Jeffrey A.;
    • Lynch, Thomas J.;
    • Haber, Daniel A.;
    • Louis, David N.;
    • Ellisen, Leif W.;
    • Borger, Darrell R.;
    • Iafrate, A. John
    Publication type:
    Article
    44
    45
    46
    47

    CORRIGENDUM: Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

    Published in:
    Nature Medicine, 2004, v. 10, n. 6, p. 649, doi. 10.1038/nm0604-649c
    By:
    • Willett, Christopher G;
    • Boucher, Yves;
    • di Tomaso, Emmanuelle;
    • Duda, Dan G;
    • Munn, Lance L;
    • Tong, Ricky T;
    • Chung, Daniel C;
    • Sahani, Dushyant V;
    • Kalva, Sanjeeva P;
    • Kozin, Sergey V;
    • Mino, Mari;
    • Cohen, Kenneth S;
    • Scadden, David T;
    • Hartford, Alan C;
    • Fischman, Alan J;
    • Clark, Jeffrey W;
    • Ryan, David P;
    • Zhu, Andrew X;
    • Blaszkowsky, Lawrence S;
    • Chen, Helen X
    Publication type:
    Article
    48

    Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

    Published in:
    Nature Medicine, 2004, v. 10, n. 2, p. 145, doi. 10.1038/nm988
    By:
    • Willett, Christopher G.;
    • Boucher, Yves;
    • Di Tomaso, Emmanuelle;
    • Duda, Dan G.;
    • Munn, Lance L.;
    • Tong, Ricky T.;
    • Chung, Daniel C.;
    • Sahani, Dushyant V.;
    • Kalva, Sanjeeva P.;
    • Kozin, Sergey V.;
    • Man Mino, Sergey V.;
    • Cohen, Kenneth S.;
    • Scadden, David T.;
    • Hartford, Alan C.;
    • Fischman, Alan J.;
    • Clark, Jeffrey W.;
    • Ryan, David P.;
    • Zhu, Andrew X.;
    • Blaszkowsky, Lawrence S.;
    • Chen, Helen X.
    Publication type:
    Article
    49
    50